Longeveron Inc. (LGVN)
NASDAQ: LGVN · Real-Time Price · USD
0.7998
-0.0002 (-0.03%)
At close: Aug 22, 2025, 4:00 PM
0.8060
+0.0062 (0.78%)
After-hours: Aug 22, 2025, 7:51 PM EDT
Longeveron Market Cap
Longeveron has a market cap or net worth of $12.14 million as of August 22, 2025. Its market cap has decreased by -67.10% in one year.
Market Cap
12.14M
Enterprise Value
2.95M
1-Year Change
-67.10%
Ranking
Category
Stock Price
$0.80
Market Cap Chart
Since the IPO on February 12, 2021, Longeveron's market cap has decreased from $172.48M to $12.14M, a decrease of -92.96%. That is a compound annual growth rate of -44.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 12.14M | -52.70% |
| Dec 31, 2024 | 25.67M | -24.83% |
| Dec 29, 2023 | 34.15M | -49.55% |
| Dec 30, 2022 | 67.68M | -72.36% |
| Dec 31, 2021 | 244.90M | 41.99% |
| Feb 12, 2021 | 172.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 638.90B |
| Johnson & Johnson | 431.79B |
| AbbVie | 372.04B |
| UnitedHealth Group | 278.42B |
| Novo Nordisk | 253.97B |
| AstraZeneca | 251.25B |
| Novartis AG | 246.51B |
| Abbott Laboratories | 230.77B |